Cargando...
Colorectal cancer: the first neoplasia found to be under immunosurveillance and the last one to respond to immunotherapy?
The first study demonstrating that human colorectal carcinoma (CRC) is under robust immunosurveillance was published a decade ago. Today, it is clear that CRC patients with Stage III lesions abundantly infiltrated by effector memory T cells have a better prognosis than subjects with Stage I neoplasm...
Gardado en:
| Publicado en: | Oncoimmunology |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Taylor & Francis
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4485723/ https://ncbi.nlm.nih.gov/pubmed/26140250 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1058597 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|